Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day 20 mg/g
Avobenzone, Octisalate and Octocrylene · CREAM · SICOS ET CIE
Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day is a cream containing avobenzone, octisalate and octocrylene at 20 mg/g, taken topical. Manufactured by SICOS ET CIE.
Key Facts
- Brand Name
- Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day
- Generic Name
- Avobenzone, Octisalate and Octocrylene
- NDC Code (Product)
51150-953- Manufacturer
- SICOS ET CIE
- Strength
- 20 mg/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 06/01/2010
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Uses - helps prevent sunburn - if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Dosage & Administration
Directions For sunscreen use: ● apply generously and evenly 15 minutes before sun exposure ● reapply at least every 2 hours ● use a water resistant sunscreen if swimming or sweating ● Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: ● limit time in the sun, especially from 10 a.m. – 2 p.m. ● wear long-sleeved shirts, pants, hats, and sunglasses ● children under 6 months of age: Ask a doctor
Warnings
Warnings For external use only
Frequently Asked Questions
What is Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day used for?
Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day contains Avobenzone, Octisalate and Octocrylene. It is a cream taken topical. Consult your doctor for specific uses.
Is Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day a controlled substance?
Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day is not classified as a controlled substance by the DEA.
What is the generic name for Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day?
The generic name for Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day is Avobenzone, Octisalate and Octocrylene. There are 11 other brand versions of Avobenzone, Octisalate and Octocrylene.
What is the NDC code for Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day 20 mg/g?
The NDC (National Drug Code) for Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day 20 mg/g is 51150-953, listed by SICOS ET CIE.
Other Avobenzone, Brands
See all →- Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Firming AntiWrinkle30 mg/mL82046-418
- Lancome Paris Renergie HPN 300 Peptide Broad Spectrum SPF 25 Sunscreen30 mg/g49967-240
- Lancome Paris High Resolution Refill 3X Triple Action Renewal Anti Wrinkle Broad Spectrum SPF 15 Sunscreen30 mg/g49967-502
- Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Firming AntiWrinkle30 mg/mL51150-418
- Lancome Paris Bienfait MultiVital Broad Spectrum SPF 30 Sunscreen30 mg/g49967-456
- Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Lift and Firming Face and Neck All Skin Types30 mg/g49967-633
- Lancome Paris Renergie HPN 300 Peptide Broad Spectrum SPF 25 Sunscreen30 mg/g51150-240
- Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Firming AntiWrinkle30 mg/mL82046-641
- Lancome Paris Absolue Hand Premium Bx Broad Spectrum SPF 15 Sunscreen Absolute Anti Age Spot Unifying And Replenishing Treatment20 mg/g49967-137
- Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen30 mg/g49967-726
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)